SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: bgscolt2/8/2025 3:45:31 PM
4 Recommendations

Recommended By
bobbseytwins2001
Davidoff
Fitzhughlaw
sukit

   of 1229
 
Investing.com

SAN DIEGO, CA – Immunity Bio, Inc., a biotechnology firm specializing in biological products, announced today the resignation of John Owen Brennan from its Board of Directors, effective immediately. Brennan, who has served on the board since 2021, stepped down from his role and all related committee positions on February 7, 2025. According to the company's filing with the Securities and Exchange Commission, his departure is not due to any disagreements with the company's operations, policies, or practices.

I thought this was a likely move by IBRX. If he couldn't help with government contacts then he really had no role, plus his security clearance was revoked so he couldn't go into some government buildings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News